Effects of Ropivacaine-Based Thoracic Paravertebral Block versus Erector Spinae Plane Block on Quality of Recovery in Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial.
무작위 임상시험
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
87 patients scheduled for elective laparoscopic colorectal cancer surgery were initially enrolled and randomly assigned.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Overall, the two block techniques provided comparable benefits for postoperative recovery and analgesia. [TRIAL REGISTRATION] ChiCTR2400089500.
[BACKGROUND] Colorectal cancer remains a leading cause of cancer-related mortality worldwide.
- 표본수 (n) 29
- 95% CI 0.09 to 5.98
- 연구 설계 randomized controlled trial
APA
Shi S, Liang Y, et al. (2026). Effects of Ropivacaine-Based Thoracic Paravertebral Block versus Erector Spinae Plane Block on Quality of Recovery in Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial.. Drug design, development and therapy, 20, 581084. https://doi.org/10.2147/DDDT.S581084
MLA
Shi S, et al.. "Effects of Ropivacaine-Based Thoracic Paravertebral Block versus Erector Spinae Plane Block on Quality of Recovery in Laparoscopic Colorectal Cancer Surgery: A Randomized Controlled Trial.." Drug design, development and therapy, vol. 20, 2026, pp. 581084.
PMID
41873336
Abstract
[BACKGROUND] Colorectal cancer remains a leading cause of cancer-related mortality worldwide. Postoperative pain can impair recovery. Thoracic paravertebral block (TPVB) and erector spinae plane block (ESPB) are regional analgesic techniques that may enhance recovery, but their comparative efficacy in colorectal surgery is not well established. This study aimed to compare the effects of TPVB and ESPB on the quality of recovery in patients undergoing colorectal cancer surgery.
[METHODS] In this single-center, single-blind, randomized controlled trial, 87 patients scheduled for elective laparoscopic colorectal cancer surgery were initially enrolled and randomly assigned. Ultimately, 85 patients were included in the per-protocol analysis, distributed as follows: the bilateral TPVB (n = 29), the bilateral ESPB (n = 28), and the control (n = 28). Both blocks were performed at the T10 level using 20 mL of 0.375% ropivacaine per side. The primary outcome was the Quality of Recovery-15 (QoR-15) scores at 24 hours postoperatively. Secondary outcomes included pain scores, overall benefit of analgesia scores (OBAS), area under the curve (AUC) analyses for these scores and opioid consumption.
[RESULTS] Both TPVB and ESPB groups had higher QoR-15 scores at 24 hours compared to controls (TPVB: 122.03 ± 4.00, ESPB: 119.00 ± 3.09, Control: 109.79 ± 2.89; both < 0.001). TPVB provided a statistically significant, yet clinically modest, improvement in recovery over ESPB at 24 hours (mean difference [MD] 3.03; 95% CI, 0.09 to 5.98; = 0.036). However, QoR‑15 AUC over 72 hours did not differ between blocks ( = 0.12). Both blocks resulted in better OBAS throughout the first 48 hours (all < 0.05). TPVB also demonstrated better early resting pain control at 6 hours ( = 0.012) but had a longer performance time than ESPB ( = 0.003). Both intervention groups reduced opioid consumption.
[CONCLUSION] Both TPVB and ESPB improve recovery quality and analgesia after laparoscopic colorectal cancer surgery. Overall, the two block techniques provided comparable benefits for postoperative recovery and analgesia.
[TRIAL REGISTRATION] ChiCTR2400089500.
[METHODS] In this single-center, single-blind, randomized controlled trial, 87 patients scheduled for elective laparoscopic colorectal cancer surgery were initially enrolled and randomly assigned. Ultimately, 85 patients were included in the per-protocol analysis, distributed as follows: the bilateral TPVB (n = 29), the bilateral ESPB (n = 28), and the control (n = 28). Both blocks were performed at the T10 level using 20 mL of 0.375% ropivacaine per side. The primary outcome was the Quality of Recovery-15 (QoR-15) scores at 24 hours postoperatively. Secondary outcomes included pain scores, overall benefit of analgesia scores (OBAS), area under the curve (AUC) analyses for these scores and opioid consumption.
[RESULTS] Both TPVB and ESPB groups had higher QoR-15 scores at 24 hours compared to controls (TPVB: 122.03 ± 4.00, ESPB: 119.00 ± 3.09, Control: 109.79 ± 2.89; both < 0.001). TPVB provided a statistically significant, yet clinically modest, improvement in recovery over ESPB at 24 hours (mean difference [MD] 3.03; 95% CI, 0.09 to 5.98; = 0.036). However, QoR‑15 AUC over 72 hours did not differ between blocks ( = 0.12). Both blocks resulted in better OBAS throughout the first 48 hours (all < 0.05). TPVB also demonstrated better early resting pain control at 6 hours ( = 0.012) but had a longer performance time than ESPB ( = 0.003). Both intervention groups reduced opioid consumption.
[CONCLUSION] Both TPVB and ESPB improve recovery quality and analgesia after laparoscopic colorectal cancer surgery. Overall, the two block techniques provided comparable benefits for postoperative recovery and analgesia.
[TRIAL REGISTRATION] ChiCTR2400089500.
MeSH Terms
Humans; Male; Female; Nerve Block; Colorectal Neoplasms; Laparoscopy; Ropivacaine; Middle Aged; Postoperative Pain; Single-Blind Method; Aged; Anesthetics, Local; Adult; Thoracic Vertebrae
같은 제1저자의 인용 많은 논문 (5)
- Effect of botulinum toxin type A on flap surgery in animal models: a systematic review and meta-analysis.
- Latent Physical Activity Patterns and Their Related Factors in Breast Cancer Patients During Chemotherapy Intervals.
- Construction of a homologous targeting exosome-based drug delivery system for colorectal cancer and evaluation of its anti-tumor efficacy.
- Biowaste-Archetyped Hierarchical Calcium Carbonate Nanoreactors Induce Tumor Bioenergetic Crisis and Reverse Cisplatin Resistance via Mitochondrial Metabolic Reprogramming.
- ME-p: A Deep Learning Method with Multimodal Learning for Protein p Prediction.